YD Bio YDES
NASDAQ YDES
$6.12 +0.20 (+3.38%)
At close: Oct 19, 2026 · 4:00 PM EDT

YD Bio (YDES) Other Accumulated Expenses (2024 - 2026)

Updated

YD Bio (YDES) reported Other Accumulated Expenses of $5,002 for the quarter ended Jun 30, 2026, down 68.3% from $15,767 a year earlier.

Analysis

YD Bio (YDES) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, YD Bio posted Other Accumulated Expenses of $6,764, down 59.2% from the prior year.

  • By year, Other Accumulated Expenses came in at $16,581 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 YD Bio 417.66 Mn 405.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 358,864.00
Dec 31, 2025 785,665.00
Jun 30, 2025 67,680.00
Dec 31, 2024 37,253.00
API Access

YD Bio Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=YDES&period=max&api_key=YOUR_API_KEY